Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers

BMC Cancer

Table 3 Multivariate analysis of disease specific survival and overall survival

Variables	Disease-specific survival					Overall survival
		N	HR	95% CI	p	HR	95% CI	p
Stage
	NMIBC	82	1			1
	MIBC	60	13.61	2.79–66.39	0.001	7.63	2.25–25.92	0.001
Combined immunostaining score for CXCL1
	None / Low	34	1			1
	Moderate	53	1.57	0.17–14.58	0.69	1.17	0.21–6.36	0.86
	High	55	3.05	0.34–27.16	0.32	2.08	0.39–10.98	0.39

HR Hazard ratio, 95% CI 95% confidence interval, NMIBC Non-muscle invasive bladder cancer, MIBC Muscle invasive bladder cancer.

ISSN: 1471-2407